Mevaldi announced it has raised new investment from ICOS Capital, with High-Tech Gründerfonds (HTGF) and ICIG Ventures also participating, as the company looks to accelerate the industrial scale-up of its technology and expand the market reach of its bio-based chemical building blocks.
In a statement shared on LinkedIn, Mevaldi said the funding will be used to move its technology further along the scale-up path and support the commercialization of “cost-effective, bio-based chemical building blocks” intended for a broad set of sustainable chemical applications. The company framed the round as a step toward turning sustainability goals into an industrial reality—where performance, scalability, and economics must align for adoption to take hold.
Mevaldi noted that the investment is an endorsement of its approach to sustainable chemistry, emphasizing that bio-based alternatives must be produced at an industrial scale and priced competitively to displace conventional incumbents. The company highlighted themes that have become central to the sector’s scale-up narrative: capital efficiency, demonstrated scalability, and evidence of market traction.
The announcement also underscores the growing investor focus on industrial technologies that can deliver climate and sustainability benefits without relying on permanent cost premiums. While many low-carbon and circular-economy concepts can succeed at lab or pilot levels, bringing new chemical building blocks into established value chains typically requires proof that processes can be reliably scaled, integrated into existing production and procurement workflows, and delivered at costs that customers can tolerate—particularly in price-sensitive industrial markets.
Mevaldi said the new backing strengthens its ability to execute against those challenges, describing the funding as support for continued scale-up and a push to bring its bio-based building blocks to market. The company did not disclose financial terms, timing, or additional details about the transaction.
